Diana Hausman's most recent trade in Immuneering Corp - Ordinary Shares Class A was a trade of 3,000 Class A Common Stock done at an average price of $3.6 . Disclosure was reported to the exchange on July 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immuneering Corp - Ordinar... | Diana F. Hausman | Director | Purchase of securities on an exchange or from another person at price $ 3.62 per share. | 02 Jul 2025 | 3,000 | 3,000 | - | 3.6 | 10,874 | Class A Common Stock |
| Immuneering Corp - Ordinar... | Diana F. Hausman | Director | Purchase of securities on an exchange or from another person at price $ 3.60 per share. | 02 Jul 2025 | 2,500 | 2,500 | - | 3.6 | 8,989 | Class A Common Stock |
| Immuneering Corp - Ordinar... | Diana F. Hausman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 33,350 | 33,350 | - | - | Stock Option | |
| Immuneering Corp - Ordinar... | Diana F. Hausman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 33,350 | 33,350 | - | - | Stock Option | |
| Zentalis Pharmaceuticals Inc | Diana F. Hausman | Chief Medical Officer | 09 May 2024 | 3,356 | 373,876 | - | 12.6 | 42,353 | Common Stock | |
| Zentalis Pharmaceuticals Inc | F. Diana Hausman | Chief Medical Officer | 01 Feb 2024 | 337,500 | 377,232 | - | 0 | Common Stock | ||
| Zentalis Pharmaceuticals Inc | Hausman Diana F. | Chief Medical Officer | 01 Feb 2024 | 337,500 | 337,500 | - | - | Stock Option (Right to Buy) | ||
| Immuneering Corp - Ordinar... | Diana F. Hausman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 17,500 | 17,500 | - | - | Stock Option | |
| Immuneering Corp - Ordinar... | Diana F. Hausman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 6,185 | 6,185 | - | - | Stock Option | |
| Immuneering Corp - Ordinar... | Diana F. Hausman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 25,200 | 25,200 | - | - | Stock Option | |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2021 | 48,750 | 48,750 | - | - | Stock Option (Right to Buy) | |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2021 | 8,125 | 8,125 | - | - | Restricted Stock Unit | |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2021 | 2,500 | 5,000 | - | - | Restricted Stock Unit | |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2021 | 2,500 | 6,425 (0%) | 0% | 0 | Common Shares | |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 34.95 per share. | 10 Mar 2021 | 1,048 | 5,377 (0%) | 0% | 35.0 | 36,631 | Common Shares |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 30.92 per share. | 07 Jan 2021 | 207 | 3,925 (0%) | 0% | 30.9 | 6,400 | Common Shares |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 55.12 per share. | 04 Dec 2020 | 6,032 | 3,718 (0%) | 0% | 55.1 | 332,476 | Common Shares |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.84 per share. | 04 Dec 2020 | 3,182 | 9,750 (0%) | 0% | 11.8 | 37,675 | Common Shares |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2020 | 3,182 | 47,673 | - | - | Stock Option (Right to Buy) | |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2020 | 2,850 | 68,028 | - | - | Stock Option (Right to Buy) | |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.82 per share. | 04 Dec 2020 | 2,850 | 6,568 (0%) | 0% | 9.8 | 27,987 | Common Shares |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 55.19 per share. | 01 Dec 2020 | 18,267 | 3,718 (0%) | 0% | 55.2 | 1,008,240 | Common Shares |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.84 per share. | 01 Dec 2020 | 14,145 | 21,985 (0%) | 0% | 11.8 | 167,477 | Common Shares |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 14,145 | 50,855 | - | - | Stock Option (Right to Buy) | |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 4,122 | 70,878 | - | - | Stock Option (Right to Buy) | |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.82 per share. | 01 Dec 2020 | 4,122 | 7,840 (0%) | 0% | 9.8 | 40,478 | Common Shares |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 55.01 per share. | 01 Dec 2020 | 701 | 3,718 (0%) | 0% | 55.0 | 38,563 | Common Shares |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 574 | 50,281 | - | - | Stock Option (Right to Buy) | |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.84 per share. | 01 Dec 2020 | 574 | 4,419 (0%) | 0% | 11.8 | 6,796 | Common Shares |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 127 | 70,751 | - | - | Stock Option (Right to Buy) | |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.82 per share. | 01 Dec 2020 | 127 | 3,845 (0%) | 0% | 9.8 | 1,247 | Common Shares |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 14 Sep 2020 | 40,000 | 3,718 (0%) | 0% | 45 | 1,800,000 | Common Shares |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.84 per share. | 14 Sep 2020 | 10,000 | 43,718 (0%) | 0% | 11.8 | 118,400 | Common Shares |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.74 per share. | 14 Sep 2020 | 10,000 | 13,718 (0%) | 0% | 15.7 | 157,400 | Common Shares |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.15 per share. | 14 Sep 2020 | 10,000 | 23,718 (0%) | 0% | 17.2 | 171,500 | Common Shares |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.82 per share. | 14 Sep 2020 | 10,000 | 33,718 (0%) | 0% | 9.8 | 98,200 | Common Shares |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2020 | 10,000 | 14,702 | - | - | Stock Option (Right to Buy) | |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2020 | 10,000 | 17,235 | - | - | Stock Option (Right to Buy) | |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2020 | 10,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Zymeworks BC Inc | Diana Hausman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2020 | 10,000 | 65,000 | - | - | Stock Option (Right to Buy) |